ClinicalTrials.gov
ClinicalTrials.gov Menu

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00115895
Recruitment Status : Active, not recruiting
First Posted : June 27, 2005
Last Update Posted : March 2, 2018
Sponsor:
Collaborator:
Helsinki University Central Hospital
Information provided by (Responsible Party):
Hanna Mäenpää, Helsinki University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 2004
  Estimated Study Completion Date : September 2020